According to Bristol-Myers Squibb latest financial reports the total liabilities of BMY is $65.67B, an decrease of -0.04% to 2022. At the end of 2022 company had $65.70B total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Bristol-Myers Squibb is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $65.67B | -0.04% |
2022 | $65.70B | -10.38% |
2021 | $73.31B | -9.05% |
2020 | $80.60B | 3.01% |
2019 | $78.25B | 520.61% |
2018 | $12.61B | - |